IDE Monoclonal Antibody (3H4) - BT-MCA0055

IDE Monoclonal Antibody (3H4)

Sizes: 20μL, 50μL, 100μL

Catalogue Numbers: BT-MCA0055-20, BT-MCA0055-50, BT-MCA0055-100

Citations, Manuals and MSDS Available upon request.

Background: This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been describe

Research Areas: Cardiovascular; Signal transduction; Neuroscience; Metabolism; Cell biology

Target Protein: IDE

Applications: WB, IHC-p, IF, ICC

Reactivity: Human

Clonality: Monoclonal

Host: Mouse

Isotype: IgG

Full Product Name: Insulin-degrading enzyme

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Storage: -20°C for 1 year

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

UniProt Accession: Human: P14735; Mouse: Q9JHR7; Rat: P35559

Synonyms: IDE; Insulin-degrading enzyme; Abeta-degrading protease; Insulin protease; Insulinase; Insulysin

GeneID: Human: 341625700

Research Use Only